Editorial Comment from Dr Teishima and Dr Matsubara to Prognostic impact of the pretreatment aspartate transaminase/alanine transaminase ratio in patients treated with first‐line systemic tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma

Saved in:
Bibliographic Details
Published inInternational journal of urology Vol. 25; no. 6; pp. 603 - 604
Main Authors Teishima, Jun, Matsubara, Akio
Format Journal Article
LanguageEnglish
Published Australia Wiley Subscription Services, Inc 01.06.2018
Subjects
Alanine
Alanine transaminase
Aspartate transaminase
Metastases
Renal cell carcinoma
Transaminase
Tyrosine kinase inhibitors
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:0919-8172
1442-2042
DOI:10.1111/iju.13592